Clinical Trial Update: Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effect of the etonogestrel/ethinyl estradiol vaginal ring on vaginal innate and inflammatory biomarkers in bacteria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• Nuvaring (etonogestrel and ethinyl estradiol)

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Vaginosis, Bacterial | Phase 4 | Status: UNKNOWN